SPECT and PET imaging in Alzheimer’s disease
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia. Beta-amyloid (Aβ) deposition and neurofibrillary tangles (NFTs) of abnormal hyperphosphorylated tau protein are the pathological hallmarks of the disease, accompanied by other pathological processes such as microglia activation. Functional and molecular nuclear medicine imaging with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) techniques provides valuable information about the underlying pathological processes, many years before the appearance of clinical symptoms. Nuclear neuroimaging in AD has made great progress in the past two decades and has extended beyond the traditional role of brain perfusion and glucose metabolism evaluation. Intense efforts in radiopharmaceuticals research have led to the development of various probes able to detect Aβ deposits, tau protein accumulation, microglia activation and neuroinflammation. As a result, SPECT and PET have proposed to serve as biomarkers in recently revised diagnostic clinical criteria for the early diagnosis of AD and the prediction of progression to AD in mild cognitive impairment (MCI) subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Positron emission tomography has been employed to visualize Aβ plaques in the brain for the diagnosis of AD, 3 however it has obvious shortcomings, such as radioligand use, limited spatial resolution and higher cost.4”
From Amyloid Plaque Imaging with a Targeted MRI Contrast Agent in a Transgenic Mouse Model of Alzheimer’s Disease (2022) · cites this paper as [4]
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET
Klunk, W. E., Koeppe, R. A., Price, J. C., Benzinger, T. L., Devous, M. D., Jagust, W. J., Johnson, K. A., Mathis, C. A., Minhas, D., Pontecorvo, M. J., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.07.003 · Cited by 1,348
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A., Ringheim, A., Långström, B., & Nordberg, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 728
Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
2010 Alzheimer's disease facts and figures
Alzheimer's Association (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.009 · Cited by 684
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
Chien, D. T., Szardenings, A. K., Bahri, S., Walsh, J. C., Mu, F., Xia, C., Shankle, W. R., Lerner, A. J., Su, M.-Y., Elizarov, A., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130098 · Cited by 675
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807
Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M.-Y., Shankle, W. R., Elizarov, A., & Kolb, H. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122059 · Cited by 651
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Sabri, O., Sabbagh, M. N., Seibyl, J., Barthel, H., Akatsu, H., Ouchi, Y., Senda, K., Murayama, S., Ishii, K., Takao, M., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.004 · Cited by 602
Barthel, H., Gertz, H.-J., Dresel, S., Peters, O., Bartenstein, P., Buerger, K., Hiemeyer, F., Wittemer-Rump, S. M., Seibyl, J., Reininger, C., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70077-1 · Cited by 591
Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
Farias, S. T., Mungas, D., Reed, B. R., Harvey, D., & DeCarli, C. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.106 · Cited by 584
Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging.
Villringer, A., & Dirnagl, U. (1995) · PubMed · Cited by 566
Hutchinson, E. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2985 · Cited by 532
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11 C-PIB PET study
Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F. E., Någren, K., Bullock, R., Walker, Z., Kennedy, A., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b23564 · Cited by 527
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
Tau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501
Landau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M., Mathis, C. A., Jagust, W. J., & Mintun, M. A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109009 · Cited by 462
Carter, S. F., Schöll, M., Almkvist, O., Wall, A., Engler, H., Långström, B., & Nordberg, A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.087031 · Cited by 442
11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 410
Amyloid Imaging with18F-Florbetaben in Alzheimer Disease and Other Dementias
Villemagne, V. L., Ong, K., Mulligan, R. S., Holl, G., Pejoska, S., Jones, G., O'Keefe, G., Ackerman, U., Tochon-Danguy, H., Chan, J. G., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089730 · Cited by 372
Pontecorvo, M. J., Devous, M. D., Navitsky, M., Lu, M., Salloway, S., Schaerf, F. W., Jennings, D., Arora, A. K., McGeehan, A., Lim, N. C., et al. (2017) · Brain · doi:10.1093/brain/aww334 · Cited by 357
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Fodero-Tavoletti, M. T., Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., et al. (2011) · Brain · doi:10.1093/brain/awr038 · Cited by 328
Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers
Zhang, D., Shen, D., & Initiative, A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033182 · Cited by 292
Okamura, N., Furumoto, S., Harada, R., Tago, T., Yoshikawa, T., Fodero-Tavoletti, M., Mulligan, R. S., Villemagne, V. L., Akatsu, H., Yamamoto, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.117341 · Cited by 290
Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease
Bloudek, L. M., Spackman, D. E., Blankenburg, M., & Sullivan, S. D. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110458 · Cited by 282
Nuclear medicine in clinical diagnosis and treatment
Tamara, L. A. (2005) · Academic Radiology · doi:10.1016/j.acra.2005.02.036 · Cited by 280
Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
Okamura, N., Furumoto, S., Fodero-Tavoletti, M. T., Mulligan, R. S., Harada, R., Yates, P., Pejoska, S., Kudo, Y., Masters, C. L., Yanai, K., et al. (2014) · Brain · doi:10.1093/brain/awu064 · Cited by 264
Morris, E., Chalkidou, A., Hammers, A., Peacock, J., Summers, J., & Keevil, S. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3228-x · Cited by 248
McKhann, G. M., Knopman, D. S., Chertkow, H. M., Hyman, B. T., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mohs, R. C., Morris, J. C., et al. (2011) · Alzheimer s & Dementia · Cited by 240
Imaging markers for Alzheimer disease: Which vs how
Frisoni, G. B., Bocchetta, M., Chételat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829d86e8 · Cited by 225
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease
Lim, Y. Y., Maruff, P., Pietrzak, R. H., Ames, D., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Szoeke, C., Martins, R. N., Masters, C. L., et al. (2014) · Brain · doi:10.1093/brain/awt286 · Cited by 210
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195
Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
Esposito, G., Giovacchini, G., Liow, J.-S., Bhattacharjee, A. K., Greenstein, D., Schapiro, M., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049619 · Cited by 183
18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
Rowe, C. C., Doré, V., Jones, G., Baxendale, D., Mulligan, R. S., Bullich, S., Stephens, A. W., De Santi, S., Masters, C. L., Dinkelborg, L., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3749-6 · Cited by 178
Matsuda, H., Mizumura, S., Nagao, T., Ota, T., Iizuka, T., Nemoto, K., Takemura, N., Arai, H., & Homma, A. (2007) · PubMed · Cited by 176
11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
Kreisl, W. C., Lyoo, C. H., Liow, J.-S., Wei, M., Snow, J., Page, E., Jenko, K. J., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.011 · Cited by 174
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
Villemagne, V. L., Furumoto, S., Fodero-Tavoletti, M. T., Mulligan, R. S., Hodges, J., Harada, R., Yates, P., Piguet, O., Pejoska, S., Doré, V., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2681-7 · Cited by 170
Wiley, C. A., Lopresti, B. J., Venneti, S., Price, J., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 163
Boutin, H., Chauveau, F., Thominiaux, C., Gregoire, M.-C., James, M. L., Trebossen, R., Hantraye, P., Dolle, F., Tavitian, B., & Kassiou, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.036764 · Cited by 160
Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R. A., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 152
Hashimoto, H., Kawamura, K., Igarashi, N., Takei, M., Fujishiro, T., Aihara, Y., Shiomi, S., Muto, M., Ito, T., Furutsuka, K., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.139550 · Cited by 151
Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale
Rowe, C. C., Jones, G., Doré, V., Pejoska, S., Margison, L., Mulligan, R. S., Chan, J. G., Young, K., & Villemagne, V. L. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171595 · Cited by 140
Chiu, C., Miller, M. C., Monahan, R., Osgood, D. P., Stopa, E. G., & Silverberg, G. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.020 · Cited by 139
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
Harada, R., Okamura, N., Furumoto, S., Furukawa, K., Ishiki, A., Tomita, N., Hiraoka, K., Watanuki, S., Shidahara, M., Miyake, M., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3035-4 · Cited by 138
Positron Emission Tomography Imaging of Neuroinflammation
Cagnin, A., Kassiou, M., Meikle, S. R., & Banati, R. B. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.04.006 · Cited by 137
Cerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Chiotis, K., Saint-Aubert, L., Savitcheva, I., Jelic, V., Andersen, P., Jonasson, M., Eriksson, J., Lubberink, M., Almkvist, O., Wall, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3363-z · Cited by 127
Hatashita, S., Yamasaki, H., Suzuki, Y., Tanaka, K., Wakebe, D., & Hayakawa, H. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2564-y · Cited by 122
Wolk, D. A., Zhang, Z., Boudhar, S., Clark, C. M., Pontecorvo, M. J., & Arnold, S. E. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302548 · Cited by 122
Agdeppa, E. D., Kepe, V., Liu, J., Small, G. W., Huang, S., Petrič, A., Satyamurthy, N., & Barrio, J. R. (2003) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2003.09.010 · Cited by 121
Barthel, H., Luthardt, J., Becker, G., Patt, M., Hammerstein, E., Hartwig, K., Eggers, B., Sattler, B., Schildan, A., Hesse, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1821-1 · Cited by 110
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
Kimura, Y., Ichise, M., Ito, H., Shimada, H., Ikoma, Y., Seki, C., Takano, H., Kitamura, S., Shinotoh, H., Kawamura, K., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160127 · Cited by 110
Early identification of MCI converting to AD: a FDG PET study
Pagani, M., Nobili, F., Morbelli, S., Arnaldi, D., Giuliani, A., Öberg, J., Girtler, N., Brugnolo, A., Picco, A., Bauckneht, M., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3761-x · Cited by 109
Sun, M., & Alkon, D. L. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00002-7 · Cited by 101
Vitali, P., Migliaccio, R., Agosta, F., Rosen, H., & Geschwind, M. (2008) · Seminars in Neurology · doi:10.1055/s-0028-1083695 · Cited by 98
In vivo tau imaging: Obstacles and progress
Villemagne, V. L., & Okamura, N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.013 · Cited by 96
Svedberg, M. M., Hall, H., Hellström‐Lindahl, E., Estrada, S., Guan, Z.-Z., Nordberg, A. K., & Långström, B. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.016 · Cited by 94
Lockhart, S. N., Baker, S. L., Okamura, N., Furukawa, K., Ishiki, A., Furumoto, S., Tashiro, M., Yanai, K., Arai, H., Kudo, Y., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158460 · Cited by 94
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
Ahmad, R. U., Postnov, A. A., Bormans, G. M., Versijpt, J. J., Vandenbulcke, M., & Laere, K. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3457-7 · Cited by 93
Advantages in functional imaging of the brain
Mier, W., & Mier, D. U. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00249 · Cited by 92
Honer, M., Gobbi, L., Knust, H., Kuwabara, H., Muri, D., Koerner, M., Valentine, H., Dannals, R. F., Wong, D. F., & Borroni, E. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.196741 · Cited by 90
[18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats
Boutin, H., Prenant, C., Maroy, R., Galea, J., Greenhalgh, A. D., Smigova, A., Cawthorne, C., Julyan, P., Wilkinson, S. M., Banister, S. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056441 · Cited by 89
Fawaz, M. V., Brooks, A. F., Rodnick, M. E., Carpenter, G. M., Shao, X., Desmond, T. J., Sherman, P., Quesada, C. A., Hockley, B. G., Kilbourn, M. R., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500103u · Cited by 86
Feeney, C., Scott, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A. P., Brooks, D. J., Nicholas, R. S., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3444-z · Cited by 81
Camp, N. V., Boisgard, R., Kühnast, B., Thezé, B., Viel, T., Grégoire, M., Chauveau, F., Boutin, H., Katsifis, A. G., Dollé, F., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1353-0 · Cited by 76
Rodriguez-Vieitez, E., Carter, S. F., Chiotis, K., Saint-Aubert, L., Leuzy, A., Schöll, M., Almkvist, O., Wall, A., Långström, B., & Nordberg, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168732 · Cited by 76
Ma, Y., Zhang, S., Li, J., Zheng, D.-M., Guo, Y., Feng, J., & Ren, W.-D. (2014) · Medicine · doi:10.1097/md.0000000000000150 · Cited by 69
Amyloid Deposition in Early Onset versus Late Onset Alzheimer's Disease
Cho, H., Seo, S. W., Kim, J.-H., Suh, M. K., Lee, J.-H., Choe, Y. S., Lee, K.-H., Kim, J. S., Kim, G. H., Noh, Y., et al. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121927 · Cited by 66
Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
Lemoine, L., Saint-Aubert, L., Marutle, A., Antoni, G., Eriksson, J. P., Ghetti, B., Okamura, N., Nennesmo, I., Gillberg, P.-G., & Nordberg, A. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0220-4 · Cited by 65
Arlicot, N., Katsifis, A. G., Garreau, L., Mattner, F., Vergote, J., Duval, S., Bodard, S., Guilloteau, D., & Chalon, S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0834-x · Cited by 64
18F-florbetaben Aβ imaging in mild cognitive impairment
Ong, K., Villemagne, V. L., Bahar-Fuchs, A., Lamb, F., Chételat, G., Raniga, P., Mulligan, R. S., Salvado, O., Putz, B., Roth, K., et al. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt158 · Cited by 64
Shao, X., Carpenter, G. M., Desmond, T. J., Sherman, P. S., Quesada, C., Fawaz, M. V., Brooks, A. F., Kilbourn, M. R., Albin, R. L., Frey, K. A., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300216t · Cited by 63
Developments in Tau PET Imaging
Zimmer, E. R., Leuzy, A., Gauthier, S., & Rosa-Neto, P. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2014.15 · Cited by 60
Talbot, P. R., Lloyd, J. J., Snowden, J. S., Neary, D., & Testa, H. (1994) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00173036 · Cited by 56
Amyloid Imaging: Poised for Integration into Medical Practice
Anand, K., & Sabbagh, M. N. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0474-y · Cited by 54
Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo
Rapoport, S. I. (2013) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.05.003 · Cited by 46
Maya, Y., Okumura, Y., Kobayashi, R., Onishi, T., Shoyama, Y., Barret, O., Alagille, D., Jennings, D. L., MAREK, K. L., Seibyl, J. P., et al. (2015) · Brain · doi:10.1093/brain/awv305 · Cited by 46
Hatashita, S., & Yamasaki, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100222 · Cited by 44
Chen, C.-J., Bando, K., Ashino, H., Taguchi, K., Shiraishi, H., Shima, K., Fujimoto, O., Kitamura, C., Matsushima, S., Uchida, K., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.146944 · Cited by 43
Grimmer, T., Wutz, C., Drzezga, A., Forster, S., Forstl, H., Ortner, M., Perneczky, R., & Kurz, A. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310010011 · Cited by 42
Tau-imaging in neurodegeneration
Bischof, G. N., Endepols, H., van Eimeren, T., & Drzezga, A. E. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.003 · Cited by 41
FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
Yousefi, B. H., von Reutern, B., Scherübl, D., Manook, A., Schwaiger, M., Grimmer, T., Henriksen, G., Förster, S., Drzezga, A. E., & Wester, H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0090-6 · Cited by 40
Shimada, H., Hirano, S., Sinotoh, H., Ota, T., Tanaka, N., Sato, K., Yamada, M., Fukushi, K., Irie, T., Zhang, M. R., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4338 · Cited by 40
Pittsburgh compound B and the postmortem diagnosis of alzheimer disease
Niedowicz, D. M., Beckett, T. L., Matveev, S., Weidner, A. M., Baig, I., Kryscio, R. J., Mendiondo, M. S., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Annals of Neurology · doi:10.1002/ana.23633 · Cited by 38
Dugger, B. N., Clark, C. M., Serrano, G., Mariner, M., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Lu, M., Fleisher, A. S., Reiman, E. M., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000028 · Cited by 38
Synthesis and preliminary evaluation of 2‐arylhydroxyquinoline derivatives for tau imaging
Tago, T., Furumoto, S., Okamura, N., Harada, R., Ishikawa, Y., Arai, H., Yanai, K., Iwata, R., & Kudo, Y. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3133 · Cited by 37
Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain
Richards, D., & Sabbagh, M. N. (2014) · Neurology and Therapy · doi:10.1007/s40120-014-0022-9 · Cited by 36
Amyloid Deposition and Cognition in Older Adults: The Effects of Premorbid Intellect
Duff, K. M., Foster, N. L., Dennett, K., Hammers, D. B., Zollinger, L. V., Christian, P. E., Butterfield, R. I., Beardmore, B. E., Wang, A. Y., Morton, K. A., et al. (2013) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/act047 · Cited by 28
Valotassiou, V. J., Papatriantafyllou, J. D., Sifakis, N., Tzavara, C. K., Tsougos, I., Psimadas, D., Fezoulidis, I. V., Kapsalaki, E. Z., Hadjigeorgiou, G. M., & Georgoulias, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150068 · Cited by 27
Self-citationSchafer, K. N., Kim, S., Matzavinos, A., & Kuret, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.066 · Cited by 24
Alzheimers Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
Valotassiou, V. J., Archimandritis, S. C., Sifakis, N., Papatriantafyllou, J. D., & Georgoulias, P. (2010) · Current Alzheimer Research · doi:10.2174/156720510792231757 · Cited by 21
Self-citationWang, M., Xu, L., Gao, M., Miller, K. D., Sledge, G. W., & Zheng, Q. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.100 · Cited by 19
Radiopharmaceuticals in Neurological and Psychiatric Disorders
Valotassiou, V. J., Wozniak, G., Sifakis, N., Demakopoulos, N., & Georgoulias, P. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408784293679 · Cited by 17
Self-citationValotassiou, V. J., Papatriantafyllou, J. D., Sifakis, N., Tzavara, C. K., Tsougos, I., Kapsalaki, E. Z., Hadjigeorgiou, G. M., & Georgoulias, P. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283599983 · Cited by 16
Self-citationKasuya, M., Meguro, K., Okamura, N., Funaki, Y., Ishikawa, H., Tanaka, N., Iwata, R., & Yanai, K. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182222bc0 · Cited by 12
Mintun, M. A., Schwarz, A. J., Joshi, A. D., Shcherbinin, S., Chien, D. C., Elizarov, A. M., Su, M., Shankle, W. R., Pontecorvo, M. J., Tauscher, J. T., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.08.003 · Cited by 10
Fernández, S., Giglio, J., Reyes, A. L., Damián, A., Pérez, C., Pérez, D. I., González, M., Oliver, P., Rey, A. M., Engler, H., et al. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0023 · Cited by 6
Ryan, K. J., Jager, P. L. D., Boyd, J., Glicksman, M. A., & Bradshaw, E. M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.397 · Cited by 1
Cited by
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095023 · Cited by 337
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Yadollahikhales, G., & Rojas, J. C. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01405-0 · Cited by 154
Review on 99mTc radiopharmaceuticals with emphasis on new advancements
Duatti, A. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.05.005 · Cited by 174
Pless, A., Ware, D., Saggu, S., Rehman, H., Morgan, J., & Wang, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1263771 · Cited by 131
Metadata
- Authors
- Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P.
- Affiliations
- University Hospital of Larissa (GR)
- National and Kapodistrian University of Athens (GR)
- University of Cyprus (CY)
- Corresponding author
- Valotassiou, Varvara
- ORCID
- Venue
- Annals of Nuclear Medicine
- Published
- 2018-08-20
- Volume
- 32
- Issue
- 9
- Pages
- 583-593
- ISSN
- 0914-7187 (ISSN-L)
- 1864-6433
- OpenAlex
- W2888363961
- Cited by
- 169
- References
- 110
- Citations by year
- 2026: 8 · 2025: 27 · 2024: 32 · 2023: 31 · 2022: 22 · 2021: 27 · 2020: 14 · 2019: 8
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Annals of Nuclear Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, single photon emission computed tomography, positron emission tomography, amyloid-beta imaging, neurofibrillary tangles, microglial activation, neuroinflammation, radiopharmaceuticals, early diagnosis, mild cognitive impairment, biomarkers, cerebral perfusion, glucose metabolism
- MeSH terms
- Alzheimer Disease, Brain, Humans, Tomography, Emission-Computed, Single-Photon, tau Proteins, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.